Dudediligence.

Biomea Fusion, Inc

BMEANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$32.8MSep ’24−$29.3MDec ’24−$29.3MMar ’25−$20.7MJun ’25−$16.4MSep ’25$4.6MDec ’25−$12.4MMar ’26−$8.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$41.7M−$83.6M−$126.1M−$144.1M−$83.5M
Net income−$41.6M−$81.8M−$117.3M−$138.4M−$61.8M
Operating cash flow−$35.4M−$62.4M−$96.6M−$119.9M−$70.4M
Free cash flow−$38.6M−$63.4M−$100.0M−$120.3Mnone on file
Cash$145.7M$111.9M$176.9M$58.3M$55.8M
Shares outstanding29.1M29.6M35.9M36.3M72.3M